Showing results (491-500 of 687) with videos related to
Sort By:
Pageof 69
Journal of Cardiovascular Pharmacology and Therapeutics|July 31, 2020
Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia: A One Center StudyVana Kolovou, Niki Katsiki, Stamatis Makrygiannis, et al.The Open Cardiovascular Medicine Journal|June 16, 2011
Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatinGenovefa Kolovou, Constantinos Mihas, Katherine Anagnostopoulou, et al.Current Vascular Pharmacology|June 25, 2010
ESVS Guidelines: Section A--prevention in patients with carotid stenosisChristos D Liapis, Peter F Bell, Dimitri P Mikhailidis, et al.American Journal of Surgery|March 24, 2017
The impact of metabolic syndrome and its components on perioperative outcomes after elective laparotomy - A prospective observational studyEleni Laou, Haralampos Milionis, Anastasios Petrou, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|February 26, 2008
Association between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudicationStella S Daskalopoulou, Mariasoosai Pathmarajah, Stavros K Kakkos, et al.Clinical Nutrition (Edinburgh, Scotland)|July 5, 2020
The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)Fjolla Zhubi-Bakija, Gani Bajraktari, Ibadete Bytyçi, et al.Clinical Science (London, England : 1979)|August 24, 2002
Reduction of endothelin-1 binding and inhibition of endothelin-1-mediated detrusor contraction by naftidrofurylRobert C Calvert, Faiz H Mumtaz, Mick R Dashwood, et al.Metabolism: Clinical and Experimental|April 14, 2019
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidenceNiki Katsiki, George Dimitriadis, George Hahalis, et al.Current Vascular Pharmacology|June 25, 2010
ESVS Guidelines: Section B - diagnosis and investigation of patients with carotid stenosisChristos D Liapis, Peter F Bell, Dimitri P Mikhailidis, et al.Current Pharmaceutical Design|January 3, 2013
A review of the cardiovascular and anti-atherogenic effects of ghrelinManfredi Rizzo, Ali A Rizvi, Emina Sudar, et al.Pageof 69